Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be presenting at the Bank of America ...

Ladies and gentlemen, thank you for standing by, and welcome to Pulmonx first quarter 2025 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded ...